Defence Therapeutics Inc.
DTCFF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $71 | $26 | $25 | $40 |
| - Cash | $2 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $2 | $2 |
| Enterprise Value | $70 | $27 | $27 | $42 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$0 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.019 | -0.018 | -0.013 | -0.03 |
| % Growth | -9% | -33.1% | 55.1% | – |
| Operating Cash Flow | -$2 | -$1 | $0 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | $0 | -$1 |